Christopher Sullivan to Treatment Outcome
This is a "connection" page, showing publications Christopher Sullivan has written about Treatment Outcome.
Connection Strength
0.335
-
Fitzpatrick TH, Lovin BD, Magister MJ, Waltonen JD, Browne JD, Sullivan CA. Surgical management of Eagle syndrome: A 17-year experience with open and transoral robotic styloidectomy. Am J Otolaryngol. 2020 Mar - Apr; 41(2):102324.
Score: 0.099
-
Marcus S, Holley AC, Persad P, Sullivan CA. Hypercalcemia in an elderly patient. JAMA Otolaryngol Head Neck Surg. 2014 Feb; 140(2):169-70.
Score: 0.066
-
Davis PL, Hardison S, Sullivan CA. Topical mithramycin-A modulates submucosal collagen deposition after esophageal burn injury in rats. Otolaryngol Head Neck Surg. 2011 Sep; 145(3):435-41.
Score: 0.055
-
Dries DJ, McGonigal MD, Malian MS, Bor BJ, Sullivan C. Protocol-driven ventilator weaning reduces use of mechanical ventilation, rate of early reintubation, and ventilator-associated pneumonia. J Trauma. 2004 May; 56(5):943-51; discussion 951-2.
Score: 0.034
-
Sterba KR, Garrett-Mayer E, Carpenter MJ, Tooze JA, Hatcher JL, Sullivan C, Tetrick LA, Warren GW, Day TA, Alberg AJ, Weaver KE. Smoking status and symptom burden in surgical head and neck cancer patients. Laryngoscope. 2017 01; 127(1):127-133.
Score: 0.020
-
Hatcher JL, Sterba KR, Tooze JA, Day TA, Carpenter MJ, Alberg AJ, Sullivan CA, Fitzgerald NC, Weaver KE. Tobacco use and surgical outcomes in patients with head and neck cancer. Head Neck. 2016 May; 38(5):700-6.
Score: 0.018
-
Vatca M, Lucas JT, Laudadio J, D'Agostino RB, Waltonen JD, Sullivan CA, Rouchard-Plasser R, Matsangou M, Browne JD, Greven KM, Porosnicu M. Retrospective analysis of the impact of HPV status and smoking on mucositis in patients with oropharyngeal squamous cell carcinoma treated with concurrent chemotherapy and radiotherapy. Oral Oncol. 2014 Sep; 50(9):869-76.
Score: 0.017
-
Goguen LA, Posner MR, Norris CM, Tishler RB, Wirth LJ, Annino DJ, Gagne A, Sullivan CA, Sammartino DE, Haddad RI. Dysphagia after sequential chemoradiation therapy for advanced head and neck cancer. Otolaryngol Head Neck Surg. 2006 Jun; 134(6):916-22.
Score: 0.010
-
Haddad R, Tishler R, Wirth L, Norris CM, Goguen L, Sullivan C, O'Donnell L, Li Y, Posner M. Rate of pathologic complete responses to docetaxel, cisplatin, and fluorouracil induction chemotherapy in patients with squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 2006 Jun; 132(6):678-81.
Score: 0.010
-
Haddad R, Colevas AD, Tishler R, Busse P, Goguen L, Sullivan C, Norris CM, Lake-Willcutt B, Case MA, Costello R, Posner M. Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: the Dana Farber Cancer Institute experience. Cancer. 2003 Jan 15; 97(2):412-8.
Score: 0.008